<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05052476</url>
  </required_header>
  <id_info>
    <org_study_id>BACTECOLIC</org_study_id>
    <nct_id>NCT05052476</nct_id>
  </id_info>
  <brief_title>First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic</brief_title>
  <acronym>BACTECOLIC</acronym>
  <official_title>First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astel Medica</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astel Medica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, open label, dose-response study will be realized at the first line with&#xD;
      Bactecal® D Liquid. The objective is to investigate Bactecal® D Liquid in the context of&#xD;
      infantile colics.&#xD;
&#xD;
      The patients will be randomized into two arms, A and B, in function of the intervention dose.&#xD;
      The quality of life of te parents as well as the daily median crying time and the number of&#xD;
      daily crying will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in parent quality of life (QoL) score</measure>
    <time_frame>Change from baseline parent QoL score at 28 days</time_frame>
    <description>By measuring parent quality of Life (QoL) score. Scale from 1 (minimum) to 7 (maximum). Higher scores mean a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of daily median crying time</measure>
    <time_frame>Change from baseline daily median crying time at 28 days</time_frame>
    <description>By measuring the mean change in crying time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the number of crying</measure>
    <time_frame>Change from baseline number of crying at 28 days</time_frame>
    <description>By measuring the numbers per day</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Colic</condition>
  <arm_group>
    <arm_group_label>Open label Bactecal® D Liquid 1 dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 1 dose of Bactecal® D Liquid by day which corresponds to 2 ml of product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open label Bactecal® D Liquid 2 doses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 2 doses of Bactecal® D Liquid by day which correspond to 4 ml of product.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bactecal® D Liquid</intervention_name>
    <description>The patients will be randomized into two arms, A and B, in function of the intervention dose</description>
    <arm_group_label>Open label Bactecal® D Liquid 1 dose</arm_group_label>
    <arm_group_label>Open label Bactecal® D Liquid 2 doses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Full term healthy infant (37-41 weeks amenorrhea)&#xD;
&#xD;
          -  Birth weight &gt;2750 g&#xD;
&#xD;
          -  Aged between 2 and 8 weeks&#xD;
&#xD;
          -  Presenting symptoms of infant colic as defined by Rome IV criteria by Zeevenhoven et&#xD;
             al. 2017&#xD;
&#xD;
          -  Signed written informed consent of the parent/tutor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Premature birth&#xD;
&#xD;
          -  Using probiotics as a treatment, different from the one that could contain the formula&#xD;
             at the time of study recruitment&#xD;
&#xD;
          -  Acute or chronic illness as judged by the investigator which avoids the participation&#xD;
             to the study .&#xD;
&#xD;
          -  Parents unable to understand the requirements of study participation as judged by the&#xD;
             investigator&#xD;
&#xD;
          -  Malnutrition as judged by a body weight/height ratio &lt;5 %&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

